Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer

Abstract

PSA levels in midlife strongly predict future lethal PCa in a US cohort subject to opportunistic screening. Risk-stratified screening on the basis of midlife PSA should be considered in men age 45 to 59 years.